Advancements in NK Cell Engineering and Bispecific Antibodies Driving the Market's Explosive Growth in Oncology.
The enormous potential of **Natural Killer (NK) cell therapeutics** stems not just from the cells themselves but from technological breakthroughs in their engineering and strategic combination with other agents, most notably **bispecific antibodies**. The inherent limitations of unmodified NK cells—specifically their short lifespan, poor persistence *in vivo*, and difficulty penetrating...
0 Yorumlar 0 hisse senetleri 133 Views 0 önizleme